Abstract
Background Emotion dysregulation is central to the development and maintenance of psychopathology, and is common across many psychiatric disorders. Neurobiological models of emotion dysregulation involve the fronto-limbic brain network, including in particular the amygdala and prefrontal cortex (PFC). Neural variability has recently been suggested as an index of cognitive flexibility. We hypothesized that within-subject neural variability in the fronto-limbic network would be related to inter-individual variation in emotion dysregulation in the context of low affective control.
Methods In a multi-site cohort (N = 166, 93 females) of healthy individuals and individuals with emotional dysregulation (attention deficit/hyperactivity disorder (ADHD), bipolar disorder (BD), and borderline personality disorder (BPD)), we applied partial least squares (PLS), a multivariate data-driven technique, to derive latent components yielding maximal covariance between blood-oxygen level-dependent (BOLD) signal variability at rest and emotion dysregulation, as expressed by affective lability, depression and mania scores.
Results PLS revealed one significant latent component (r = 0.62, p = 0.001), whereby greater emotion dysregulation was associated with increased neural variability in the amygdala, hippocampus, ventromedial, dorsomedial and dorsolateral PFC, insula and motor cortex, and decreased neural variability in occipital regions. This spatial pattern bears a striking resemblance to the fronto-limbic network, which is thought to subserve emotion regulation, and is impaired in individuals with ADHD, BD, and BPD.
Conclusions Our work supports emotion dysregulation as a transdiagnostic dimension with neurobiological underpinnings that transcend diagnostic boundaries, and adds evidence to neural variability being a relevant proxy of neural efficiency.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Swiss National Center of Competence in Research; Synapsy: the Synaptic Basis of Mental Diseases, financed by the Swiss National Science Foundation (grant number 51NF40-158776), a grant of the Swiss National Science Foundation to JMA (grant number 32003B-156914) and the FondaMental Suisse Foundation. VK was partly supported by the Singapore National Research Foundation (NRF) Fellowship (Class of 2017) and the Singapore Ministry of Defense (Project CURATE). Her work utilized resources provided by the Center for Functional Neuroimaging Technologies, NIH P41EB015896 and instruments supported by NIH 1S10RR023401, NIH 1S10RR019307, and NIH 1S10RR023043 from the Athinoula A. Martinos Center for Biomedical Imaging at the Massachusetts General Hospital. The computational work was partially performed on resources of the National Supercomputing Centre, Singapore (https://www.nscc.sg). This work was supported by the French ANR under the VIP (MNP 2008) Project; the Investissements d'Avenir programs managed by the ANR under references ANR-11-IDEX-004-02 (Labex BioPsy) and ANR-10-COHO-10-01; and the Fondation pour la Recherche Medicale (Bioinformatique pour la biologie 2014). This work was also supported by research grants from Grenoble University Hospital (http://www.chu-grenoble.fr/). The Grenoble MRI facility IRMaGE was partly funded by the French program Investissement d'avenir run by the Agence Nationale pour la Recherche (http://www.agence-nationale-recherche.fr/): Grant Infrastructure d'Avenir en Biologie Sante (grant number ANR-11-INBS-0006). The authors report no biomedical financial interests or potential conflicts of interest.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The research was conducted according to the principles of the Declaration of Helsinki and was approved by the University of Geneva research Ethics Committee (CER 13 081), the Paris CPP Ile de France IX Ethics Committee, and the Grenoble University Hospital Ethics Committee (no. 2011 A00425 36).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data is available upon request.
